Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal

Authors: Venkatraman, Navin, Ndiaye, Birahim Pierre, Bowyer, Georgina, Wade, Djibril, Sridhar, Saranya, Wright, Daniel, Powlson, Jonathan, Ndiaye, Ibrahima, Dièye, Siry, Thompson, Craig, Bakhoum, Momar, Morter, Richard, Capone, Stefania, Del Sorbo, Mariarosaria, Jamieson, Sophie, Rampling, Tommy, Datoo, Mehreen, Roberts, Rachel, Poulton, Ian, Griffiths, Oliver, Ballou, W. Ripley, Roman, François, Lewis, David J. M., Lawrie, Alison, Imoukhuede, Egeruan, Gilbert, Sarah C., Dieye, Tandakha N., Ewer, Katie J., Mboup, Souleymane, Hill, Adrian V. S.

Source: The Journal of Infectious Diseases, 2019 Apr . 219(8), 1187-1197.

Access URL: https://www.jstor.org/stable/26634016

Systems analysis of protective immune responses to RTS,S malaria vaccination in humans

Authors: Kazmin, Dmitri, Nakaya, Helder I., Lee, Eva K., Johnson, Matthew J., van der Most, Robbert, van den Berg, Robert A., Ballou, W. Ripley, Jongert, Erik, Wille-Reece, Ulrike, Ockenhouse, Christian, Aderem, Alan, Zak, Daniel E., Sadoff, Jerald, Hendriks, Jenny, Wrammert, Jens, Ahmed, Rafi, Pulendran, Bali

Source: Proceedings of the National Academy of Sciences of the United States of America, 2017 Feb . 114(9), 2425-2430.

Access URL: https://www.jstor.org/stable/26479506

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

Authors: Regules, Jason A., Cicatelli, Susan B., Bennett, Jason W., Paolino, Kristopher M., Twomey, Patrick S., Moon, James E., Kathcart, April K., Hauns, Kevin D., Komisar, Jack L., Qabar, Aziz N., Davidson, Silas A., Dutta, Sheetij, Griffith, Matthew E., Magee, Charles D., Wojnarski, Mariusz, Livezey, Jeffrey R., Kress, Adrian T., Waterman, Paige E., Jongert, Erik, Wille-Reece, Ulrike, Volkmuth, Wayne, Emerling, Daniel, Robinson, William H., Lievens, Marc, Morelle, Danielle, Lee, Cynthia K., Yassin-Rajkumar, Bebi, Weltzin, Richard, Cohen, Joe, Paris, Robert M., Waters, Norman C., Birkett, Ashley J., Kaslow, David C., Ballou, W. Ripley, Ockenhouse, Christian F., Vekemans, Johan

Source: The Journal of Infectious Diseases, 2016 Sep 01. 214(5), 762-771.

Access URL: http://www.jstor.org/stable/44007147

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Authors: De Santis, Olga, Audran, Régine, Pothin, Emilie, Warpelin-Decrausaz, Loane, Vallotton, Laure, Wuerzner, Grégoire, Cochet, Camille, Estoppey, Daniel, Steiner-Monard, Viviane, Lonchampt, Sophie, Thierry, Anne-Christine, Mayor, Carole, Bailer, Robert T, Mbaya, Olivier Tshiani, Zhou, Yan, Ploquin, Aurélie, Sullivan, Nancy J, Graham, Barney S, Roman, François, De Ryck, Iris, Ballou, W Ripley, Kieny, Marie Paule, Moorthy, Vasee, Spertini, François, Genton, Blaise

Source: In The Lancet Infectious Diseases March 2016 16(3):311-320

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

Authors: Tapia, Milagritos D, Sow, Samba O, Lyke, Kirsten E, Haidara, Fadima Cheick, Diallo, Fatoumata, Doumbia, Moussa, Traore, Awa, Coulibaly, Flanon, Kodio, Mamoudou, Onwuchekwa, Uma, Sztein, Marcelo B, Wahid, Rezwanul, Campbell, James D, Kieny, Marie-Paule, Moorthy, Vasee, Imoukhuede, Egeruan B, Rampling, Tommy, Roman, Francois, De Ryck, Iris, Bellamy, Abbie R, Dally, Len, Mbaya, Olivier Tshiani, Ploquin, Aurélie, Zhou, Yan, Stanley, Daphne A, Bailer, Robert, Koup, Richard A, Roederer, Mario, Ledgerwood, Julie, Hill, Adrian V S, Ballou, W Ripley, Sullivan, Nancy, Graham, Barney, Levine, Myron M

Source: In The Lancet Infectious Diseases January 2016 16(1):31-42

Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults

Authors: Kester, Kent E., Gray Heppner, D., Jr, Moris, Philippe, Ofori-Anyinam, Opokua, Krzych, Urszula, Tornieporth, Nadia, McKinney, Denise, Delchambre, Martine, Ockenhouse, Christian F., Voss, Gerald, Holland, Carolyn, Beckey, Jolie Palensky, Ballou, W. Ripley, Cohen, Joe

Source: In Vaccine 20 November 2014 32(49):6683-6691

The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study

Authors: Spertini, François, Audran, Régine, Lurati, Floriana, Ofori-Anyinam, Opokua, Zysset, Frédéric, Vandepapelière, Pierre, Moris, Philippe, Demoitié, Marie-Ange, Mettens, Pascal, Vinals, Carlota, Vastiau, Ilse, Jongert, Erik, Cohen, Joe, Ballou, W. Ripley

Source: In Tuberculosis March 2013 93(2):179-188

Expression of Genes Associated with Immunoproteasome Processing of Major Histocompatibility Complex Peptides Is Indicative of Protection with Adjuvanted RTS,S Malaria Vaccine

Authors: Vahey, Maryanne T., Wang, Zhining, Kester, Kent E., Cummings, James, Heppner, D. Gray, Nau, Martin E., Ofori-Anyinam, Opokua, Cohen, Joe, Coche, Thierry, Ballou, W. Ripley, Ockenhouse, Christian F.

Source: The Journal of Infectious Diseases, 2010 Feb . 201(4), 580-589.

Access URL: https://www.jstor.org/stable/27794462

Randomized, Double-Blind, Phase 2a Trial of Faltiparum Malaria Vaccines RTS,S/AS01B and RTS.S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Authors: RTS,S Vaccine Evaluation Group, Kester, Kent E., Cummings, James F., Ofori-Anyinam, Opokua, Ockenhouse, Christian F., Krzych, Urszula, Moris, Philippe, Schwenk, Robert, Nielsen, Robin A., Debebe, Zufan, Pinelis, Evgeny, Juompan, Laure, Williams, Jack, Dowler, Megan, Stewart, V. Ann, Wirtz, Robert A., Dubois, Marie-Claude, Lievens, Marc, Cohen, Joe, Ballou, W. Ripley, Heppner,, D. Gray

Source: The Journal of Infectious Diseases, 2009 Aug 01. 200(3), 337-346.

Access URL: https://www.jstor.org/stable/40255003

Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children

Authors: Sacarlal, Jahit, Aide, Pedro, Aponte, John J., Renom, Montse, Leach, Amanda, Mandomando, Inácio, Lievens, Marc, Bassat, Quique, Lafuente, Sarah, Macete, Eusébio, Vekemans, Johan, Guinovart, Caterina, Sigaúque, Betuel, Sillman, Maria, Milman, Jessica, Dubois, Marie-Claude, Demoitié, Marie-Ange, Thonnard, Joelle, Menéndez, Clara, Ballou, W. Ripley, Cohen, Joe, Alonso, Pedro L.

Source: The Journal of Infectious Diseases, 2009 Aug 01. 200(3), 329-336.

Access URL: https://www.jstor.org/stable/40255002

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

Authors: Olotu, Ally, Lusingu, John, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Msham, Salum, Lang, Trudie, Gould, Jayne, Dubois, Marie-Claude, Jongert, Erik, Vansadia, Preeti, Carter, Terrell, Njuguna, Patricia, Awuondo, Ken O, Malabeja, Anangisye, Abdul, Omar, Gesase, Samwel, Mturi, Neema, Drakeley, Chris J, Savarese, Barbara, Villafana, Tonya, Lapierre, Didier, Ballou, W Ripley, Cohen, Joe, Lemnge, Martha M, Peshu, Norbert, Marsh, Kevin, Riley, Eleanor M, von Seidlein, Lorenz, Bejon, Philip

Source: In The Lancet Infectious Diseases 2011 11(2):102-109

Four year immunogenicity of the RTS,S/AS02 A malaria vaccine in Mozambican children during a phase IIb trial

Authors: Aide, Pedro, Dobaño, Carlota, Sacarlal, Jahit, Aponte, John J., Mandomando, Inácio, Guinovart, Caterina, Bassat, Quique, Renom, Montse, Puyol, Laura, Macete, Eusebio, Herreros, Esperanza, Leach, Amanda, Dubois, Marie-Claude, Demoitie, Marie-Ange, Lievens, Marc, Vekemans, Johan, Loucq, Christian, Ballou, W. Ripley, Cohen, Joe, Alonso, Pedro L.

Source: In Vaccine 2011 29(35):6059-6067

Evaluation of the immune response to RTS, S/AS01 and RTS, S/AS02 adjuvanted vaccines

Authors: Leroux-Roels, Geert, Leroux-Roels, Isabel, Clement, Frédéric, Ofori-Anyinam, Opokua, Lievens, Marc, Jongert, Erik, Moris, Philippe, Ballou, W Ripley, Cohen, Joe

Source: Human vaccines & immunotherapeutics. 10(8):2211-2219

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050681259.0x000001&indx=1&recIds=ETOCvdc_100050681259.0x000001

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

Authors: Cummings, James F., Spring, Michele D., Schwenk, Robert J., Ockenhouse, Christian F., Kester, Kent E., Polhemus, Mark E., Walsh, Douglas S., Yoon, In-Kyu, Prosperi, Christine, Juompan, Laure Y., Lanar, David E., Krzych, Urszula, Hall, B. Ted, Ware, Lisa A., Stewart, V. Ann, Williams, Jack, Dowler, Megan, Nielsen, Robin K., Hillier, Collette J., Giersing, Birgitte K., Dubovsky, Filip, Malkin, Elissa, Tucker, Kathryn, Dubois, Marie-Claude, Cohen, Joe D., Ballou, W. Ripley, Jr, D. Gray Heppner

Source: In Vaccine 2010 28(31):5135-5144

Safety and Immunogenicity of a Recombinant Parvovirus B19 Vaccine Formulated with MF59C.1

Authors: Ballou, W. Ripley, Reed, Jennifer L., Noble, William, Young, Neal S., Koenig, Scott

Source: The Journal of Infectious Diseases, 2003 Feb . 187(4), 675-678.

Access URL: https://www.jstor.org/stable/30085586

Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites

Authors: Hoffman, Stephen L., Goh, Lucy M. L., Luke, Thomas C., Schneider, Imogene, Le, Thong P., Doolan, Denise L., Sacci, John, de la Vega, Patricia, Dowler, Megan, Paul, Chris, Gordon, Daniel M., Stoute, Jose A., Church, L. W. Preston, Sedegah, Martha, Heppner, D. Gray, Ballou, W. Ripley, Richie, Thomas L.

Source: The Journal of Infectious Diseases, 2002 Apr . 185(8), 1155-1164.

Access URL: https://www.jstor.org/stable/30137785

Vaccination Utilizing the FimCH Complex as a Strategy to Prevent Escherichia coli Urinary Tract Infections

Authors: Langermann, Solomon, Ballou, W. Ripley

Source: The Journal of Infectious Diseases, 2001 Mar 01. 183, s84-s86.

Access URL: https://www.jstor.org/stable/30109424

Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria

Authors: RTS,S Malaria Vaccine Evaluation Group, Kester, Kent E., McKinney, Denise A., Tornieporth, Nadia, Ockenhouse, Christian F., Heppner, D. Gray, Hall, Ted, Krzych, Urszula, Delchambre, Martine, Voss, Gerald, Dowler, Megan G., Palensky, Jolie, Wittes, Janet, Cohen, Joe, Ballou, W. Ripley

Source: The Journal of Infectious Diseases, 2001 Feb . 183(4), 640-647.

Access URL: https://www.jstor.org/stable/30109363

Potent Induction of Focused Th1-Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a Recombinant Plasmodium falciparum Malaria Vaccine

Authors: Lalvani, Ajit, Moris, Phillipe, Voss, Gerald, Pathan, Ansar A., Kester, Kent E., Brookes, Roger, Lee, Edwin, Koutsoukos, Marguerite, Plebanski, Magdalena, Delchambre, Martine, Flanagan, Katie L., Carton, Cecile, Slaoui, Moncef, Van Hoecke, Christian, Ballou, W. Ripley, Hill, Adrian V. S., Cohen, Joe

Source: The Journal of Infectious Diseases, 1999 Nov 01. 180(5), 1656-1664.

Access URL: https://www.jstor.org/stable/30110465

Sporozoite Vaccine Induces Genetically Restricted T Cell Elimination of Malaria from Hepatocytes

Authors: Hoffman, Stephen L., Isenbarger, Daniel, Long, Gary W., Sedegah, Martha, Szarfman, Ana, Waters, Leslie, Hollingdale, Michael R., Van Der Meide, Peter H., Finbloom, David S., Ballou, W. Ripley

Source: Science, 1989 Jun 01. 244(4908), 1078-1081.

Access URL: https://www.jstor.org/stable/1704001